Ernst Schlögl

Cross‐validation of prognostic scores in myelodysplastic syndromes on 386 patients from a single institution confirms importance of cytogenetics

Michael Pfeilstöcker, Regina Reisner, Thomas Nösslinger et al. · British Journal of Haematology · 1999 · 82 citations · Full text

Medicine, Genetics, Hematology +17

Anagrelide for thrombocytosis in myeloproliferative disorders

Michael Steurer, Guenther Gastl, Wieslaw‐Wiktor Jedrzejczak et al. · Cancer · 2004 · 78 citations · Full text

Medicine, Hematology, Pharmacology +9

Pre‐fibrotic/early primary myelofibrosis vs. WHO‐defined essential thrombocythemia: The impact of minor clinical diagnostic criteria on the outcome of the disease

Georg Jeryczynski, Jürgen Thiele, Bettina Gisslinger et al. · American Journal of Hematology · 2017 · 65 citations · Full text

Medicine, Hematology, Pathology +16

Extensive pleural and pericardial effusion in chronic myeloid leukemia during treatment with dasatinib at 100 mg or 50 mg daily

Maria‐Theresa Krauth, Susanne Herndlhofer, Maria‐Theresa Schmook et al. · Haematologica · 2010 · 61 citations · Full text

Medicine, Oncology, Pharmacotherapy +6

Variability of nm23-H1/NDPK-A expression in human lymphomas and its relation to tumour aggressiveness

D N T Aryee, Ingrid Simonitsch, Isabella Mosberger et al. · British Journal of Cancer · 1996 · 39 citations · Full text

Medicine, Oncology, Pathology +13